High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
US10233197B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jul 16, 2012 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | Jul 16, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of antimicrobials and antimicrobial-related compounds, which are capable of crossing biological barriers with high penetration efficiency. The HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.